Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Foot
- Limb Ischemia
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 90 years
- Gender
- Both males and females
Description
Disease or disorder under study: Critical ischemia of the lower limbs in diabetic patients without the possibility of revascularization. Main valuation variable: Proportion of Adverse Events related to treatment.
Disease or disorder under study: Critical ischemia of the lower limbs in diabetic patients without the possibility of revascularization. Main valuation variable: Proportion of Adverse Events related to treatment.
Tracking Information
- NCT #
- NCT04466007
- Collaborators
- Clinica Universidad de Navarra, Universidad de Navarra
- Hospital Universitario La Paz
- Gregorio Marañón Hospital
- Hospital Clínico Universitario de Valladolid
- Hospital Universitario Virgen de la Arrixaca
- University of Salamanca
- Hospital General Universitario de Alicante
- Hospital Universitario La Fe
- Hospital Victoria Eugenia Cruz Roja Española
- Investigators
- Not Provided
Get Well Soon